Point72 (DIFC)’s Idexx Laboratories IDXX Stock Holding History

Point72 (DIFC)’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-7,275	Closed	-$3.65M	–	1664
2024 Q1	$3.93M	Buy	+7,275	New	+$3.98M	0.12%	242

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Point72 (DIFC)'s IDXX Position: Q2 2024 in Review

Point72 (DIFC) sold out of Idexx Laboratories (IDXX) in Q2 2024, closing a stake of 7,275 shares — an estimated $3.65M sold.

Point72 (DIFC) first reported a position in IDXX in Q1 2024 and held it in 1 quarter. The position peaked at $3.93M in Q1 2024. 1,110 funds tracked by Wall St. Rank hold IDXX as of Q2 2024.

Point72 (DIFC) reported no remaining Idexx Laboratories position as of Q2 2024 after selling out during the quarter.
Point72 (DIFC) sold 7,275 Idexx Laboratories shares in Q2 2024, an estimated $3.65M.
Point72 (DIFC) first reported a position in Idexx Laboratories in Q1 2024 and held it in 1 quarter.
Point72 (DIFC)'s Idexx Laboratories position peaked at $3.93M in Q1 2024.
1,110 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2024.

Based on Point72 (DIFC)'s 13F filing for Q2 2024, filed 14 Aug 2024.